Post-earnings recap
Reported
Wed, Aug 5, 2009
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Amicus Therapeutics reported a loss per share that was better than expected, but the lack of revenue figures may have raised concerns among investors. The stock reacted negatively, dropping nearly 7%. Investors will likely be looking for more clarity in future reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.51 | N/A | +18.66% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.